What companies are 2162.HK's competitors?

Keymed Biosciences Inc. (2162.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 2162.HK compare to its peers?

The peer comparison table on this page shows Keymed Biosciences Inc. (2162.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 2162.HK operate in?

Keymed Biosciences Inc. (2162.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2162.HK

Keymed Biosciences Inc.

HKSE·Biotechnology · Healthcare

HK$83.60HK$3.40−3.91%

Market capHK$24.63B·Market closed·Jul 22 8:08 AM UTC

Frequently Asked Questions About 2162.HK

What companies are 2162.HK's competitors?: Keymed Biosciences Inc. (2162.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2162.HK compare to its peers?: The peer comparison table on this page shows Keymed Biosciences Inc. (2162.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2162.HK operate in?: Keymed Biosciences Inc. (2162.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2162.HK

Keymed Biosciences Inc.

HKSE·Biotechnology · Healthcare

HK$83.60HK$3.40−3.91%

Market capHK$24.63B·Market closed·Jul 22 8:08 AM UTC

Peers


9969.HK	InnoCare Pharma Limited	HK$14.48	HK$21.6B
9688.HK	Zai Lab Limited	HK$16.12	HK$18.2B
0013.HK	HUTCHMED (China) Limited	HK$17.83	HK$15.3B
9989.HK	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	HK$4.44	HK$15.0B
6855.HK	Ascentage Pharma Group International	HK$37.60	HK$14.0B
9887.HK	Nanjing Leads Biolabs Co Ltd	HK$66.05	HK$13.1B
1952.HK	Everest Medicines Limited	HK$25.72	HK$9.0B
2157.HK	Lepu Biopharma Co., Ltd.	HK$4.86	HK$8.8B
6185.HK	CanSino Biologics Inc.	HK$24.34	HK$8.5B
2591.HK	Guangzhou Innogen Pharmaceutl Grp Co Ltd	HK$8.34	HK$3.8B

Frequently Asked Questions About 2162.HK

What companies are 2162.HK's competitors?: Keymed Biosciences Inc. (2162.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2162.HK compare to its peers?: The peer comparison table on this page shows Keymed Biosciences Inc. (2162.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2162.HK operate in?: Keymed Biosciences Inc. (2162.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.